Rethinking Recruitment Strategies in Rare Disease Clinical Trials
Rare cardiovascular diseases are on the rise. In fact, there’s a 1 in 10 chance you know someone with a rare disease. Now more than ever, it’s important to throttle the recruitment and retention obstacles in rare disease clinical trials to enable new treatments for this growing patient population.
During this webinar, we will uncover the following:
- Cardiovascular and rare disease patient landscape
- The importance of advocacy groups in rare disease clinical trials
- The three I’s: Informed. Involved. Innovative. Does your CRO check the boxes?
